|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,596,522 |
|
|
Indirect Value
|
$12,923,651,413 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,005,247,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 35 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2012-01-13 |
4 |
B |
$16.46 |
$96,794 |
I/I |
5,856 |
355,839 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-05 |
4 |
B |
$5.54 |
$96,860 |
I/I |
17,480 |
58,273 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-03-09 |
4 |
B |
$18.28 |
$98,260 |
I/I |
5,375 |
38,467 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-10 |
4 |
B |
$16.12 |
$98,403 |
I/I |
5,934 |
254,763 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-07 |
4 |
S |
$12.25 |
$99,435 |
I/I |
(8,114) |
996,791 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-05 |
4 |
S |
$8.11 |
$100,285 |
I/I |
(12,317) |
215,796 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-26 |
4 |
B |
$1.59 |
$102,196 |
I/I |
64,420 |
5,849,271 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-21 |
4 |
B |
$5.90 |
$102,811 |
I/I |
17,008 |
2,475,408 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$103,080 |
I/I |
5,102 |
92,236 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$105,631 |
I/I |
(7,180) |
243,178 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-27 |
4 |
B |
$2.06 |
$106,340 |
I/I |
51,172 |
5,529,735 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-23 |
4 |
B |
$4.07 |
$106,342 |
I/I |
26,145 |
3,214,580 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$106,410 |
I/I |
(7,233) |
244,980 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-04-30 |
4 |
B |
$12.56 |
$106,830 |
I/I |
8,447 |
223,060 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-30 |
4 |
S |
$12.03 |
$106,913 |
I/I |
(8,887) |
540,961 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$107,365 |
I/I |
20,347 |
608,349 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-02-10 |
4 |
B |
$16.93 |
$109,058 |
I/I |
6,401 |
113,044 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-08 |
4 |
B |
$10.00 |
$109,359 |
I/I |
10,080 |
125,771 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-10-05 |
4 |
B |
$18.18 |
$109,408 |
I/I |
6,017 |
295,436 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-25 |
4 |
B |
$1.60 |
$109,558 |
I/I |
68,534 |
5,784,851 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-11 |
4 |
B |
$7.47 |
$111,940 |
I/I |
14,979 |
2,396,756 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-11 |
4 |
B |
$27.66 |
$112,088 |
I/I |
4,052 |
179,045 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$112,343 |
I/I |
4,225 |
203,107 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$113,892 |
I/I |
3,944 |
1,384,149 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-26 |
4 |
B |
$18.13 |
$113,962 |
I/I |
6,287 |
272,995 |
1.5 |
- |
|
1397 Records found
|
|
Page 35 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|